Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Mesalamine price, strengths & recalls

Generic of Pentasa, Canasa, Lialda

Pharmacies pay $22.25 for 30 tablets of Mesalamine 1200 mg delayed-release tablet this week, and from $14.52 to $129.64 across its 6 priced strengths and forms. 33 manufacturers make it. It is in shortage (being discontinued). 1 recall is ongoing. Its official label last changed on February 16, 2024.

Being discontinued1 open recallGeneric
Pharmacies pay$22.25for 30 tablets of 1200 mg delayed-release tablet-5.0% in 4 weeks
Fair cash price
$36.09
Strengths
6
Makers
33
Updated
Nov 11

Mesalamine price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
400 mg delayed-release capsule$2.64$79.15 / 30 capsules-2.3%+19.0%
800 mg delayed-release tablet$4.32$129.64 / 30 tablets+7.5%-0.9%
1200 mg delayed-release tablet$0.7416$22.25 / 30 tablets-5.0%-21.8%
66.7 mg/mL enema$0.0996$41.84 / 420 mL+1.2%-45.1%
375 mg (24 hr) extended-release capsule$0.4841$14.52 / 30 capsules+1.3%+6.7%
500 mg extended-release capsuleNot priced this week
1000 mg suppository$1.28$38.39 / 30 suppositorys-0.3%-18.2%

The lowest cost per capsule is 375 mg (24 hr) extended-release capsule at $0.4841. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of mesalamine

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

In shortage3 products are short or being discontinued
1 ongoing recall10 recalls on record, latest Mar 6, 2024

Shortages

  • Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)Takeda Pharmaceuticals USA Inc. · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Product is anticipated to be available until December 31, 2027
  • Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)Takeda Pharmaceuticals USA Inc. · Being discontinued Sep 16, 2026 · Updated Sep 16, 2026Product is anticipated to be available until December 31, 2027
  • Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)Mylan Pharmaceuticals Inc., a Viatris Company · Being discontinued Aug 25, 2026 · Updated Aug 25, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 10 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for mesalamine? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedFebruary 16, 2024
Version1
EffectiveFeb 15, 2024
Read the label

These highlights do not include all the information needed to use MESALAMINE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MESALAMINE DELAYED-RELEASE TABLETS. MESALAMINE delayed-release tablets, for oral use Initial U.S. Approval: 1987

Recent major changes (as listed on the label)

Warnings and Precautions, Renal Impairment (

5.1) 11/2022

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022000 · Takeda Pharms USA
First approved
January 16, 2007 (19 years ago)
Latest approved change
October 14, 2026
Approved label
PDF, Oct 20, 2026
Generic makers
27 approved generic applications on the market

Mesalamine questions

How much does mesalamine cost without insurance?

Pharmacies pay about $22.25 for 30 tablets of mesalamine 1200 mg delayed-release tablet ($0.7416 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $36.09. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of mesalamine?

Mesalamine is sold as Pentasa, Canasa, Lialda. The generic has the same active ingredient and usually costs far less.

Is mesalamine in shortage?

Yes. 3 products are listed as in shortage or being discontinued (being discontinued). See which ones.

Has mesalamine been recalled?

10 recalls on record, 1 ongoing. Recalls name specific lots - check yours.

When did the mesalamine label last change?

The official label was last updated on February 16, 2024 (version 1). See what changed.

Talk about mesalamine

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.